Full Press Release Details
ANAVEX LIFE SCIENCES CORP.
CONSOLIDATED BALANCE SHEETS
July 15, 2015 and September 30, 2014
| ASSETS | ||||||
| July 15, | September 30, | |||||
| 2015 | 2014 | |||||
| Current | ||||||
| Cash | $ | 8,025,039 | $ | 7,262,138 | ||
| Prepaid expenses | 16,054 | 89,117 | ||||
| Total current assets | 8,041,093 | 7,351,255 | ||||
| Equipment | 1,749 | 2,247 | ||||
| Total assets | $ | 8,042,842 | $ | 7,353,502 | ||
| LIABILITIES | ||||||
| Current | ||||||
| Accounts payable and accrued liabilities | $ | 911,040 | $ | 1,249,084 | ||
| Promissory notes payable | 90,412 | 192,065 | ||||
| Total current liabilities | 1,001,452 | 1,441,149 | ||||
| Non-interest bearing liabilities | 16,990 | 5,719,727 | ||||
| Total liabilities | 1,018,442 | 7,160,876 | ||||
| STOCKHOLDERS' EQUITY | ||||||
| Capital stock | ||||||
| Authorized: 400,000,000 common shares, par value $0.001 per share Issued and outstanding: 95,562,007 common shares (September 30, 2014 - 47,200,237) | 95,563 | 47,201 | ||||
| Additional paid-in capital | 66,807,196 | 52,078,750 | ||||
| Common stock to be issued | 777,415 | 640,000 | ||||
| Accumulated deficit | (60,655,774 | ) | (52,573,325 | ) | ||
| Total stockholders' equity | 7,024,400 | 192,626 | ||||
| Total liabilities and stockholders' equity | $ | 8,042,842 | $ | 7,353,502 |